World Immunisation Week marked by ABPI reception in House of Commons

pharmafile | April 28, 2016 | News story | Medical Communications ABPI, immunisations 

The ABPI vaccine group joined a host of figures at a parliamentary reception to mark World Immunisation Week.

Parliamentarians, policy makers, commissioners, patient organisations and professional groups joined together to discuss the contribution that vaccines make to the NHS’s agenda on prevention of ill health

Guest speakers included Professor Andrew Scott, London School of Hygiene and Topical Medicine, David Sinclair, International Longevity Centre UK, and Dr Harish Madhava, medical director Pfizer Vaccines, UK & Ireland. As the contribution of vaccines, the trio also spoke about the opportunities arising from the research into and development of new vaccines and vaccine technologies, including the potential of vaccination in addressing the challenge of antimicrobial resistance.

When it was founded, the NHS vaccinated against two diseases. Today it vaccinates against 20, and there are currently 300 vaccines in development in the UK and beyond. Vaccination is only rivalled by clean water in terms of reducing infectious diseases and deaths.

Sinclair notes: “Today’s long lives are a testament to the importance of immunisation. It has proved a remarkably cost-effective health intervention, significantly reducing the impact of vaccine preventable diseases.”

Dr Madhava adds: “Vaccination has saved more lives and prevented more serious diseases than any advance in recent medical history but there are still significant health needs both in the UK and globally that vaccines research is trying to address. Continued commitment to vaccination by the government, the NHS and other health systems is essential to maintaining global investment in research and development.”

Sean Murray

Related Content


The November 2020 issue of Pharmafocus is available to read free online now!

The latest monthly edition of Pharmafocus is available to read for free online now!


UK life sciences industry does not want no-deal Brexit, says ABPI Chief

Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …


ABPI Chief Executive Mike Thompson to retire by the end of 2019

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …

Latest content